Бізнес · 30.03.19941 хв читання
Akorn, Inc., et al.; Withdrawal of Approval of 18 Abbreviated Antibiotic Applications
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA) is withdrawing approval of 18 abbreviated antibiotic applications (AADA's). The holders of the AADA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.